152 related articles for article (PubMed ID: 18402525)
1. Emerging role of intensity-modulated radiation therapy in anorectal cancer.
Meyer JJ; Willett CG; Czito BG
Expert Rev Anticancer Ther; 2008 Apr; 8(4):585-93. PubMed ID: 18402525
[TBL] [Abstract][Full Text] [Related]
2. Advanced radiation therapy technologies in the treatment of rectal and anal cancer: intensity-modulated photon therapy and proton therapy.
Meyer J; Czito B; Yin FF; Willett C
Clin Colorectal Cancer; 2007 Jan; 6(5):348-56. PubMed ID: 17311699
[TBL] [Abstract][Full Text] [Related]
3. Intensity-modulated radiation therapy.
Lee NY; Terezakis SA
J Surg Oncol; 2008 Jun; 97(8):691-6. PubMed ID: 18493919
[TBL] [Abstract][Full Text] [Related]
4. Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer.
Fonteyne V; De Gersem W; De Neve W; Jacobs F; Lumen N; Vandecasteele K; Villeirs G; De Meerleer G
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1013-20. PubMed ID: 19386427
[TBL] [Abstract][Full Text] [Related]
5. The normal tissue sparing obtained with simultaneous treatment of pelvic lymph nodes and bladder using intensity-modulated radiotherapy.
Søndergaard J; Høyer M; Petersen JB; Wright P; Grau C; Muren LP
Acta Oncol; 2009; 48(2):238-44. PubMed ID: 18759144
[TBL] [Abstract][Full Text] [Related]
6. Intensity-modulated radiation therapy for anal malignancies: a preliminary toxicity and disease outcomes analysis.
Pepek JM; Willett CG; Wu QJ; Yoo S; Clough RW; Czito BG
Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1413-9. PubMed ID: 20231064
[TBL] [Abstract][Full Text] [Related]
7. Potential advantages of intensity-modulated radiation therapy in gynecologic malignancies.
Jhingran A
Semin Radiat Oncol; 2006 Jul; 16(3):144-51. PubMed ID: 16814154
[TBL] [Abstract][Full Text] [Related]
8. Intensity-modulated radiotherapy as primary therapy for prostate cancer: report on acute toxicity after dose escalation with simultaneous integrated boost to intraprostatic lesion.
Fonteyne V; Villeirs G; Speleers B; De Neve W; De Wagter C; Lumen N; De Meerleer G
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):799-807. PubMed ID: 18407430
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer.
Mell LK; Tiryaki H; Ahn KH; Mundt AJ; Roeske JC; Aydogan B
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1504-10. PubMed ID: 18640499
[TBL] [Abstract][Full Text] [Related]
10. [Which intensity modulated radiation therapy? From "step and shoot" to volumetric modulated arc therapy, point of view of the radiation oncologist].
Vieillot S; Fenoglietto P; Moscardo CL; Aillères N; Lemanski C; Dubois JB; Azria D
Cancer Radiother; 2010 Oct; 14(6-7):550-3. PubMed ID: 20724189
[TBL] [Abstract][Full Text] [Related]
11. Intensity-modulated radiation therapy for gynecologic cancers: pitfalls, hazards, and cautions to be considered.
Randall ME; Ibbott GS
Semin Radiat Oncol; 2006 Jul; 16(3):138-43. PubMed ID: 16814153
[TBL] [Abstract][Full Text] [Related]
12. The effect of intensity-modulated radiotherapy and high dose rate brachytherapy on acute and late radiotherapy-related adverse events following chemoradiotherapy of anal cancer.
Saarilahti K; Arponen P; Vaalavirta L; Tenhunen M
Radiother Oncol; 2008 Jun; 87(3):383-90. PubMed ID: 18501454
[TBL] [Abstract][Full Text] [Related]
13. Comparison of IMRT treatment plans between linac and helical tomotherapy based on integral dose and inhomogeneity index.
Shi C; Peñagarícano J; Papanikolaou N
Med Dosim; 2008; 33(3):215-21. PubMed ID: 18674686
[TBL] [Abstract][Full Text] [Related]
14. Proton radiation therapy for head and neck cancer.
Chan AW; Liebsch NJ
J Surg Oncol; 2008 Jun; 97(8):697-700. PubMed ID: 18493920
[TBL] [Abstract][Full Text] [Related]
15. RapidArc volumetric modulated therapy planning for prostate cancer patients.
Kjaer-Kristoffersen F; Ohlhues L; Medin J; Korreman S
Acta Oncol; 2009; 48(2):227-32. PubMed ID: 18855157
[TBL] [Abstract][Full Text] [Related]
16. Preoperative radiation treatment for rectal cancer: comparison of target coverage and small bowel NTCP in conventional vs. 3D-conformal planning.
Cella L; Ciscognetti N; Martin G; Liuzzi R; Punzo G; Solla R; Farella A; Salvatore M; Pacelli R
Med Dosim; 2009; 34(1):75-81. PubMed ID: 19181259
[TBL] [Abstract][Full Text] [Related]
17. Power against prostate cancer. Intensity-modulated radiation therapy and interstitial brachytherapy.
Cash JC
Adv Nurse Pract; 2006 Sep; 14(9):37-42. PubMed ID: 16972442
[No Abstract] [Full Text] [Related]
18. Combined intensity-modulated radiation therapy and brachytherapy in the treatment of cervical cancer.
Macdonald DM; Lin LL; Biehl K; Mutic S; Nantz R; Grigsby PW
Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):618-24. PubMed ID: 18407429
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of IMRT to cover pelvic nodes while escalating the dose to the prostate gland: dosimetric data on 35 consecutive patients.
Bayouth JE; Pena J; Culp L; Brack C; Sanguineti G
Med Dosim; 2008; 33(3):180-90. PubMed ID: 18674682
[TBL] [Abstract][Full Text] [Related]
20. Role of intensity-modulated radiation therapy in gastrointestinal cancer.
Bockbrader M; Kim E
Expert Rev Anticancer Ther; 2009 May; 9(5):637-47. PubMed ID: 19445580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
